Pfizer's Internal Medicines' AI-Driven Cardiometabolic Drug Discovery Institute needs to establish AI-based drug discovery collaborations and partnerships to build a collaborative ecosystem where AI and bench scientists work side-by-side to co-create value for patients.
Requirements
- Contemporary knowledge of the application of AI to solve drug discovery problems.
- Strong track record of managing and delivering results from complex alliances between academic and industry stakeholders
- Experience developing collaborative research plans with milestone-based incentives
- Ability to effectively facilitate complex, strategic conversations.
Responsibilities
- Focus on identifying, implementing and managing high profile collaborative or incubator partnerships that advance the integration of AI-driven strategies into the discovery and development of novel cardiometabolic drug candidates.
- Establish appropriate oversight and metrics for portfolio of collaborative projects to measure success and demonstrate value generation
- Function as an interface between the IM, Business Development (BD), Legal, Discovery Network and other supporting lines to help navigate collaborations and maximize return on investments in external science.
- Actively manage collaboration and partnership risks, devising and implementing appropriate mitigation strategies.
- Communicate collaboration status to senior leaders and act as a champion for the asset to ensure appropriate resources (budget and FTEs) are secured and deployed to facilitate delivery of the collaboration plan.
Other
- PhD or MD with at least 15 years experience in relevant Internal Medicine-based scientific discipline(s)
- Broad understanding of cardiometabolic disease biology
- Strong leadership and presentation and skills
- Track record of successfully working effectively with multidisciplinary teams in collaborative environments
- Entrepreneurial thinking coupled with strong organizational skills.
